Issue link: http://www.e-digitaleditions.com/i/579724
24 OCTOBER2015 Inhalation Where? Orange County Convention Center Orlando, FL, US When? October 25-29, 2015 Registration: Register online at www.aaps.org/annualmeeting/ Pre-Conference Workshops: Sat Oct 24: 8:00 a.m. – 4:00 p.m. Sun Oct 25: 8:00 a.m. – 4:00 p.m. Conference: Sun Oct 25: 4:30 p.m.– 8:00 p.m. Mon Oct 26: 7:30 a.m. – 5:00 p.m. Tue Oct 27: 7:30 a.m. – 9:30 p.m. Wed Oct 28: 9:40 a.m. – 9:30 p.m. Thu Oct 29: 7:30 a.m. – 11:00 a.m. Exhibition: Sun Oct 25: 6:30 p.m.– 8:00 p.m. Mon Oct 26: 8:30 a.m. – 5:00 p.m. Tue Oct 27: 8:30 a.m. – 9:30 p.m. Wed Oct 28: 8:30 a.m. – 1:30 p.m. Post-Conference Open Forum: Thu Oct 29: 12:00 p.m. – 3:30 p.m. For more information: American Association of Pharmaceutical Scientists (AAPS) Tel: +1 703 243-2800 www.aaps.org/annualmeeting Previewing the 2015 AAPS Annual Meeting and Exposition The 2015 AAPS Annual Meeting and Exposition will be held October 25-29 at the Orange County Convention Center in Orlando, FL, US. The con- ference will open with a presentation by keynote speaker Jack Andraka. At only age 15, he invented an inexpensive early detection test for pancreatic, ovarian and lung cancers. Still a teenager now, Andraka's groundbreaking results have earned him international recognition, most notably a 2014 Jefferson Award, the United States' most prestigious public service award. Following the opening session, an evening reception will be held on the exhibition floor. Scientific program The annual meeting will include an extensive range of scientific presenta- tions in diverse formats including work- shops, short courses, sunrise sessions and symposia. Presentations related to inhalation will include: • A Sunday full-day short course: Characterization methods for aggre- gates and particles in peptide and small protein formulations • A Tuesday morning sunrise session: Can you print your product? Recent advances in 3-dimensional printing for pharmaceutical applications • A Tuesday afternoon symposium: Challenges and future prospects of alternative delivery of biologics • A Wednesday afternoon symposium: T h i n k i n g b e y o n d t h e t a b l e t — Enhancing drug delivery capabilities from discovery to development to support modality agnostic pipelines • A Thursday morning sunrise session: Nuts and bolts of systemic bioavail- ability trial design for local delivery and what do you do with the data? This session will include: Bioavail- ability trial design for products deliv- ered via the inhalation route. • A Thursday morning symposium: The best of the rest—Drug transport across non-traditional biological bar- r i e r s . T h i s s e s s i o n w i l l i n c l u d e : Inhalation biopharmaceutics—Do transporters matter in the lung? The Inhalation and Nasal Technology Focus Group (INTFG) will hold its Town Hall meeting on Tuesday, Octo- ber 27, 4:00-5:00 PM. Exposition Various companies that serve the inhalation market will be exhibiting during the conference. As early Sep- tember, the following Inhalation adver- tisers are scheduled to appear. Those companies with ads in this issue of Inhalation are listed in bold type. A complete, updated list of exhibitors can be found on the conference website. B Brookfield Engineering Buchi Labotechnik AG C Capsugel Catalent Pharma Solutions F Freeman Technology G Gateway Analytical H Horiba Scientific Hovione K Kemwell Biopharma M Malvern Instruments MSP Corporation Multisorb Technologies P PPD Q Qualicaps S S-Matrix Suheung-America Corporation T 3M Drug Delivery Systems